Glyceraldehyde-3-Phosphate Dehydrogenase: Difference between revisions
Jump to navigation
Jump to search
Andrew Swart (talk | contribs) No edit summary |
No edit summary |
||
| (21 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
<StructureSection load='3gpd' size='340' side='right' caption='Human glyceraldehyde-3-phosphate dehydrogenase complex with NAD and sulfate, [[3gpd]]' scene=''> | |||
== Function == | == Function == | ||
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a very important enzyme in the production of energy. | '''Glyceraldehyde-3-phosphate dehydrogenase''' (GAPDH) is a very important enzyme in the production of energy and in photosynthesis. In the production of energy this enzyme catalyzes the sixth step in the process of breaking down glucose, also known as [[glycolysis]] which occurs in organisms of all phyla. The sixth step consists of of the oxidation of GAP by [[NAD]] and an inorganic phosphate to yield 1,3 bisphosphoglycerate. In photosynthesis, which is carried out by plants and algae, this enzyme uses '''NADPH''' in the reverse reaction in a step in the [[Calvin cycle]], which fixes gaseous CO<sub>2</sub> into carbohydrate. Though these are its main functions, GAPDH has been shown to perform other functions including transcription activation, initiation of apoptosis, and ER to Golgi apparatus vesicle transportation <ref>PMID: 22851451</ref>. However, this page will focus on GAPDH’s role in glycolysis. See [[2pkq]] for the plant Calvin Cycle enzyme. See [[Glycolysis Enzymes]] and [[Carbon Fixation]]. | ||
== Structure == | == Structure == | ||
GAPDH most commonly exists as what looks to be a dimer. Interesting though, the two monomers of the enzyme are not exactly the same. While one side consists only of parallel and antiparallel beta-sheets, the other monomer is made up of both <scene name='Nathan_Line_sandbox_3/Secondary_structure/1'>beta-sheets and alpha helixes</scene>. | GAPDH most commonly exists as what looks to be a dimer. Interesting though, the two monomers of the enzyme are not exactly the same. While one side consists only of parallel and antiparallel beta-sheets, the other monomer is made up of both <scene name='Nathan_Line_sandbox_3/Secondary_structure/1'>beta-sheets and alpha helixes</scene>. Though each monomer does not have to exact same sequence, each does contain replicate active sites and function. This is consistent with the following SCOP information: | ||
Class: Alpha and beta proteins (a/b) | Class: Alpha and beta proteins (a/b) | ||
| Line 22: | Line 21: | ||
== Regulation == | == Regulation == | ||
GAPDH is not a highly regulated step with in the glycolytic pathway because of relatively low energy transitions that occur between steps five and nine. However, there are a few items that must be present for the reaction to proceed. GAPDH is inactivated by the alkylation of iodoacetate, in which the Iodine inhibits the active site by binding to the Sulfur present in the cystine residue. If the active site is blocked by by an inhibitor such as Iodine then the reaction will stop. Also NAD oxidizes the GAP, so the availability of hydrogen and inorganic phosphates also could effect the rates of the reaction. The reason this step is not highly regulated is because Iodine is not present in the blood stream and the absence of both hydrogen and inorganic phosphates will cause the reaction to yield before this step is met. | GAPDH is not a highly regulated step with in the glycolytic pathway because of relatively low energy transitions that occur between steps five and nine. However, there are a few items that must be present for the reaction to proceed. GAPDH is inactivated by the alkylation of iodoacetate, in which the Iodine inhibits the active site by binding to the Sulfur present in the cystine residue. If the active site is blocked by by an inhibitor such as Iodine then the reaction will stop. Also NAD oxidizes the GAP, so the availability of hydrogen and inorganic phosphates also could effect the rates of the reaction. The reason this step is not highly regulated is because Iodine is not present in the blood stream and the absence of both hydrogen and inorganic phosphates will cause the reaction to yield before this step is met. | ||
== Reaction Mechanism == | == Reaction Mechanism == | ||
The mechanism of the glycolysis reaction is fairly straight forward. After the aldehyde enters the <scene name='Nathan_Line_sandbox_3/Active_site/3'>active site</scene> (highlighted in green), the sulfhydryl group from <scene name='Nathan_Line_sandbox_3/Cystine/7'> | The mechanism of the glycolysis reaction is fairly straight forward. After the aldehyde enters the <scene name='Nathan_Line_sandbox_3/Active_site/3'>active site</scene> (highlighted in green), the sulfhydryl group from <scene name='Nathan_Line_sandbox_3/Cystine/7'>Cysteine 151</scene> attacks the nucleophilic carbon to form a thiohemiacetal. This intermediate undergoes oxidation due to a hydride transfer to a nearby NAD+ forming a thioester. From here, a phosphate group enters and attacks the same carbonyl while at the same time it is separated from the cystine by the protonated <scene name='Nathan_Line_sandbox_3/Histidine/5'>Histidine 178</scene> group. This produces the desired 1,3-bisphosphoglycerate. Though cysteine-151 and histidine-178 are direct contributers to the catalytic process, other residues also influence the activity of this enzyme indirectly. <scene name='Nathan_Line_sandbox_3/Other/2'>Thr-210 and Arg-233</scene> are two such residues that contribute to the binding of the reactants rather than the catalytic mechanism. Regulation of GAPDH occurs through its coupling with the PGK reaction. This coupling is needed due to the slightly positive delta G of the glycolysis. The larger negative delta G of the PGK reaction results in the following overall net reaction with a delta G of -12.1 kJ/mol: | ||
GAP + Pi + NAD+ + ADP ==> 3PG + NADH + ATP | GAP + Pi + NAD+ + ADP ==> 3PG + NADH + ATP | ||
| Line 32: | Line 30: | ||
For additional information, see: [[Carbohydrate Metabolism]] | For additional information, see: [[Carbohydrate Metabolism]] | ||
<br /> | <br /> | ||
==3D structures of glyceraldehyde-3-phosphate dehydrogenase== | |||
[[Glyceraldehyde-3-phosphate dehydrogenase 3D structures]] | |||
</StructureSection> | |||
==References== | ==References== | ||
1) Voet, D, Voet, J, & Pratt, C. (2008) | 1) Voet, D, Voet, J, & Pratt, C. (2008) | ||
2)Family: Glyceraldehyde-3-phosphate dehydrogenase-like, N-terminal domain. Retrieved from: http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.d.c.b.d.html | |||
2)Family: Glyceraldehyde-3-phosphate dehydrogenase-like, N-terminal domain. | |||
3) <ref group="xtra">PMID:17676935</ref><references group="xtra"/> | 3) <ref group="xtra">PMID:17676935</ref><references group="xtra"/> | ||
| Line 44: | Line 46: | ||
5) <ref group="xtra">PMID:20164570</ref><references group="xtra"/> | 5) <ref group="xtra">PMID:20164570</ref><references group="xtra"/> | ||
6) <ref group="xtra">PMID: 22851451</ref><references group="xtra"/> | |||
[[Category:Topic Page]] | |||